Recent News

• 05.29.2025 - The Impact of Drug Testing Policies on Student Safety
• 05.20.2025 - The Future of Policy Underwriting: Why More Insurance Companies Are Turning to Hair Testing
• 05.16.2025 - Psychemedics Named “Most Innovative Drug Testing Company of the Year”
• 05.15.2025 - The Intersection of Legalization and Workplace Safety: Navigating the Challenges of Drug Use in the Workplace
• 04.24.2025 - The Hidden Dangers of Delta-8 and Delta-9 in Safety-Sensitive Jobs: A Growing Concern in the Trucking Industry
• 04.10.2025 - Why Faculty Drug Testing Is Key to Ensuring Campus Safety
• 03.13.2025 - The Evolving Role of Drug Testing in a Post-Pandemic Workforce
• 03.04.2025 - 5 Signs Substance Abuse May Be Affecting Your Workforce
• 03.03.2025 - Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights
• 02.27.2025 - How Auto Insurance Providers Can Promote Safer Roads Through Drug-Free Driving Initiatives

Recent Filings

• 03.24.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 03.19.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments